Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrous oxide plus intranasal fentanyl versus IV ketamine for pediatric fracture reduction
ACTRN12619000555156Phase 3Not yet recruiting
- Sponsor
- David Bishop
- Start
- Sep 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in bone fracture (Fx) comparing Nitrous oxide plus intranasal fentanyl with Intravenous ketamine (2 arms). Primary endpoints: Parental satisfaction with the procedure and Overall parental judgement of the child's experience. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
nitrous oxidefentanylketamine
03
Conditions
bone fracture (Fx)
Beyond the preview
Go deeper on ACTRN12619000555156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000555156.